Annie Mitsak
InvestorPartner at Cure Ventures Β· Principal at Omega Funds
Boston, Massachusetts, United States
FoundedAlessa Therapeutics
About
Partner with over ten years in academic licensing and venture investing. Previously spent over six years on the Omega Funds investment team and worked at MIT's Technology Licensing Office.
Experience
- Triton Therapeutics, Inc.Board Membercurrent2025 β present
- Alessa Therapeutics, Inc.Board Membercurrent2025 β present
- Cure VenturesPartnercurrent2023 β presentBoston, Massachusetts, United States
- Photys TherapeuticsBoard Observer2021 β 2022
- Rectify PharmaBoard Observer2021 β 2022
- Scorpion TherapeuticsBoard Observer2021 β 2022
- Anjarium BiosciencesBoard Observer2021 β 2022
- Omega FundsPrincipal2019 β 2022
- Omega FundsAssociate2015 β 2019Boston, MA
- Ikena OncologyBoard Observer2020 β 2021
- Checkmate PharmaceuticalsBoard Observer2020
- Trevi Therapeutics, Inc.Member Board Of Directors2018 β 2020
- Massachusetts Institute of Technology (MIT)Associate Technology Licensing Officer2014 β 2015
- Massachusetts Institute of Technology (MIT)Technology Licensing Associate2012 β 2014Cambridge, MA
- Nelsen BiomedicalIndependent Consultant2015
- University of MichiganPostdoctoral fellow2012Ann Arbor, MI
- Kaplan Test Prep and AdmissionsGRE Instructor2007
- Penn State UniversityResearch Assistant2005
- Johns Hopkins UniversityResearch Assistant2004Baltimore, MD
Education
- University of MichiganPhD, Biomedical Engineering2006 β 2012
- University of MichiganM.S., Biomedical Engineering2006 β 2007
- University of VirginiaBS, Biomedical Engineering2002 β 2006
Skills & more
Contract NegotiationDrafting AgreementsPeer MentoringPatent Portfolio AnalysisBiomedical EngineeringLicensing
From Annie's professional profile.
Same school
Also attended University of Michigan413
Erik TorenbergGeneral Partner at Andreessen HorowitzKarim FarisInvestor at GV (Google Ventures)Glen AndersonPartner at Monta Vista CapitalAlexandra FarmerPrincipal at Intel Capital, North AmericaHannah KrootMarketing Lead at Intel CapitalScott ShawChief of Staff at Intel Capital
+ 407 more
Also attended University of Virginia341
Alexis OhanianFounder & General Partner of Seven Seven SixAndy FligelSenior Managing Director at Intel CapitalKandace ElamVice President of GTM Talent at Menlo VenturesTrevor KienzleInvestor at Correlation VenturesFrank RotmanCo-Founder and Partner Emeritus at QED InvestorsMegan LightcapPartner, Creator Fund at Slow Ventures
+ 335 more
Shared employers
Also worked at Alessa Therapeutics, Inc.1
Also worked at Anjarium Biosciences1
Also worked at Omega Funds14
Nessan BerminghamInvestor at Khosla VenturesLiam FlahertyInvestor at Silversmith Capital PartnersRichard LimManaging Partner at Cure VenturesJohn MaraganoreAdvisor at Oak HC/FTPaulina HillPartner at Sanofi VenturesFrancesco DraettaManaging Director at Omega Funds
+ 8 more
Also worked at Massachusetts Institute of Technology (MIT)325
Aileen LeeFounder & Managing Partner of Cowboy VenturesMatt HuangCo-founder and Managing Partner at ParadigmScott BillerInvestor at GV (Google Ventures)Noubar AfeyanInvestor at Flagship PioneeringVyas RamananVenture Partner at Third Rock VenturesRhie LimPartner, Global Strategy at One Way Ventures
+ 319 more
Investments
Per SEC Form D filings.
Colleagues at Cure Ventures
Albert J. Robichaud
Partner at Cure Ventures
Bill Amsbaugh
CTO and Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
James Vath
Partner at Cure Ventures
Network6
Alex Delbridge
Senior Associate at Omega Funds
Bernard Davitian
Partner at Omega Funds
Francesco Draetta
Managing Director at Omega Funds
Katie Kerfoot
Vice President at Omega Funds
Michael Powell
Partner at Omega Funds
Thomas Goebel
Principal at Omega Funds
Investors connected to Annie in public investor directories β a warm-intro map.




















.webp)






